IonQ CapEx decreased by 4.8% to $8.37M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 262.6%, from $2.31M to $8.37M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 20.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.32M | $2.30M | $2.49M | $2.67M | $4.35M | $1.36M | $955.00K | $1.19M | $1.23M | $4.13M | $7.16M | $3.14M | $7.49M | $3.77M | $3.59M | $2.31M | $1.19M | $4.13M | $8.79M | $8.37M |
| QoQ Change | — | +73.8% | +8.1% | +7.4% | +62.8% | -68.8% | -29.7% | +24.1% | +3.5% | +237.1% | +73.2% | -56.1% | +138.5% | -49.7% | -4.7% | -35.8% | -48.3% | +245.9% | +113.0% | -4.8% |
| YoY Change | — | — | — | — | +228.5% | -40.9% | -61.6% | -55.7% | -71.8% | +204.1% | +649.6% | +165.0% | +510.8% | -8.8% | -49.8% | -26.5% | -84.1% | +9.5% | +144.6% | +262.6% |